Abstract | Analysis of chromosomal translocation sequence locations in human lymphomas has provided valuable clues about the mechanism of the translocations and when they occur. Biochemical analyses on the mechanisms of DNA breakage and rejoining permit formulation of detailed models of the human chromosomal translocation process in lymphoid neoplasms. Most human lymphomas are derived from B cells in which a DNA break at an oncogene is initiated by activation-induced deaminase (AID). The partner locus in many cases is located at one of the antigen receptor loci, and this break is generated by the recombination activating gene (RAG) complex or by AID. After breakage, the joining process typically occurs by non-homologous DNA end-joining (NHEJ). Some of the insights into this mechanism also apply to translocations that occur in non-lymphoid neoplasms.
Most chromosomal translocations consist of a breakage phase involving two chromosome breaks and then a joining phase 1 (FIG. 1) . For translocations that occur in lymphoid neoplasms, chromosome breaks are usually caused by either activation-induced deaminase (AID; also known as AICDA) or the recombination activating gene (RAG) complex [1] [2] [3] [4] . For the small subset of lymphoid neoplasm-associated translocations in which AID or the RAG complex are not involved, there is a short list of causes that also apply to non-lymphoid cells, which are not the focus of this Review.
Reciprocal translocations are the most common type of translocation in lymphoid neoplasms. Two chromosome breaks each generate two DNA ends, resulting in a total of four ends, which all must be rejoined if the translocation is to be a reciprocal exchange of the two chromosome arms. The translocation process is less well understood for carcinomas, which are often found to be non-reciprocal by the time that they become clinically apparent 5 . During the joining phase, nucleotide loss from the two DNA ends means that we can know only that the break occurred somewhere in that zone (Supplementary information S1 (figure), S2 (figure)). Thus, the joining phase determines the positional window in which the original DNA break occurred, and we must work backwards from this window to determine the sequence motifs that contributed to the original breakage mechanism. For this reason, this Review begins at the end -namely, with the joining phase, before devoting the remainder of the discussion to the more complex subject of how the chromosome breaks occur in the first place.
In this Review, the emphasis is on human lymphoid translocations because the breakage phase for these translocations is better understood than for other neoplasms. However, the summary of the joining phase applies to all human chromosomal translocations, regardless of the tissue of origin. In addition, the emphasis here is on understanding why lymphoid translocations occur in preferred DNA sequence locations, or hot spots, because this information provides insight into the biochemical mechanism driving the breakage process. Biological factors, such as which oncogene or which intron within a given oncogene is involved, are also important, as discussed briefly below.
The joining phase of translocations After two chromosomal breaks arise, new configurations generate two derivative chromosomes (each with its own centromere) in a stable reciprocal translocation 6, 7 . The newly formed junctions of most human lymphoid translocations have the canonical features of non-homologous DNA end-joining (NHEJ) 8, 9 (Supplementary information S1 (figure)). These typically include nucleotide loss from the DNA ends (Supplementary information S2 (figure)); alignment of any terminal microhomology (0-3 bp) between the two DNA ends to guide the rejoining process; and template-independent nucleotide insertion by either DNA polymerase μ (Pol μ) or Pol λ, or by terminal deoxynucleotidyltransferase (TdT; also known as DNTT) in lymphoid cells. TdT activity is strictly template independent whereas the activities of Pol μ and Pol λ are predominantly template dependent, but have a limited degree of template-independent
Lymphoid neoplasms
Malignancies of B or T cells. If the malignant cells are primarily in the spleen, lymph nodes or other peripheral lymphoid tissues, they are lymphomas. If the malignant cells are primarily in the blood and bone marrow, they are called lymphoid leukaemias. Acute lymphoblastic leukaemia (ALL) can be considered both a lymphoma and a leukaemia in humans.
Activation-induced deaminase
(AID). A cytidine deaminase that converts C to T (or methyl-C to U) in B cells of all vertebrates when it is expressed (predominantly in germinal centres, but at low levels in pre-B cells). AID is not expressed in T cells. 
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Recombination activating gene (RAG) complex
Antigen receptors of the vertebrate immune system rely on RAG1 and RAG2, which form the RAG complex, which creates double-strand DNA breaks at specific sequences called recombination signal sequences (RSSs).
Reciprocal translocations
These are stable only if each derivative chromosome has one centromere; otherwise, one chromosome is lost due to lack of a centromere, and the other chromosome suffers repeated breakage-fusionbridge cycles.
activity (usually <3 nt) 6 . Such nucleotide additions are called N-nucleotides (N-nts) or N-regions, which was the original designation given for TdT additions 10 . TdT is expressed only in early T and B cells (pro-B, pre-B, pro-T and pre-T cells) in humans to increase junctional diversity during the normal V(D)J recombination process
. The presence of extensive N-nts in the junctions of many human lymphoid chromosomal translocations is one indication that most lymphoid neoplasm-associated translocations in patients occur during the pro-B and pre-B phases of B cell differentiation, and correspondingly in early T cells 1 
.
Terminal microhomology use arises when nucleotides that are the same between two DNA termini align with one another, followed by resection of the excess DNA 'flaps' , resulting in only one block of microhomology being preserved in the final junction. The apparent frequency of this is not as high in the junctions of human lymphoid chromosomal translocations as it is in other instances of double-strand DNA break (DSB) repair by NHEJ 11, 12 . This might be because TdT-mediated additions to DNA ends may generate new terminal microhomology that was not present in the original DNA ends, and thus, such alignment may not be recognizable as microhomology use. By contrast, a process that is known as alternative DNA end-joining (a-EJ; which can also be referred to as microhomology-mediated end-joining (MMEJ)) is noted for requiring >3 nt of terminal microhomology alignment. It is not yet clear whether a-EJ is an independent pathway or merely substitution for missing NHEJ components 13 . In translocations in mice, it is possible that there is a more robust a-EJ process that is more apparent in experimental mice that lack NHEJ components 7 . For naturally arising human chromosomal translocations, however, the joining phase is due to NHEJ (which is sometimes called classical-or canonical-NHEJ (c-NHEJ) to distinguish it from the less defined a-EJ 14 ). One unusual feature of human lymphoid translocation-associated NHEJ events is templated nucleotides (T-nts) 15, 16 . T-nts are present in only a small subset of translocation junctions in human lymphoid neoplasms, whereas the other features mentioned above are present in most lymphoid translocation junctions. T-nts are rarely found in mouse NHEJ-mutant-induced translocations or in human non-lymphoid cancer-associated translocations 15, 16 . T-nts occur when nucleotides appear to be copied from either of the two DNA ends and then incorporated into the final junction in either a direct orientation to create a short duplication or an inverted orientation to create a short inversion. T-nts are likely to be due to slippage and template-dependent synthesis by either Pol μ or Pol λ 6 . In summary, NHEJ is the primary process for joining DNA ends that arise from breaks that lead to translocations. Except for TdT, all the enzymes that participate in NHEJ are present in all cells and appear to be relatively stable across the cell cycle 6 . The resection that occurs during NHEJ makes the precise location of the original break ambiguous. This is why breaks from many patient translocations must be examined as a collective set to evaluate whether there are specific sequence motifs at the preferred hot spots of translocation, which are discussed in the next sections.
Causes of chromosome breaks I now turn to the more complex topic of how chromosomal breaks initially arise. The list of general causes of chromosomal breaks applies to all living cells and includes exposure to ionizing radiation, reactive oxygen species (ROS; such as the peroxide ion (O 2 2− )), replication across a DNA nick, pathological activity by nuclear enzymes such as nucleases, particularly at fragile sites, failed topoisomerase II reactions, and mechanical or topo logical stress. These same general causes occur in lymphoid cells 6 (FIG. 1) . Additionally, in lymphoid cells, the physiological functions of the RAG complex (through V(D)J recombination; BOX 1) or of AID (through immunoglobulin heavy (IGH) locus class switch recombination (CSR) and somatic hyper mutation (SHM); BOXES 2, 3) can go awry and contribute substantially to translocations [1] [2] [3] [4] . The develop mental times of expression of RAG and AID are depicted in Supplementary information S3 (figure), and this is relevant in considering the mechanisms of breakage (discussed below). . During S and G2 phases of the cell cycle, homology-directed repair is common because the two sister chromatids are in close proximity, providing a nearby homology donor. Homology-directed repair includes homologous recombination (HR) and single-strand annealing (SSA). Proteins involved in the repair pathways are also shown. AID, activation-induced deaminase; APE1, apurinic-apyrimidinic endonuclease 1; CSR, class switch recombination; DNA-PKcs, DNA-dependent kinase catalytic subunit; ERCC, excision-repair cross-complementation group; MRE11A, meiotic recombination 11 homologue A; NBS1, Nijmegen breakage syndrome 1; Pol, DNA polymerase; RAG, recombination activating gene; UDG, uracil-DNA glycosylase; XLF, XRCC4-like factor. Before discussing the role of the RAG complex and AID in lymphoid malignancies, it is useful to emphasize that most lymphoid chromosomal translocations require two DSBs. These two DSBs may have independent causes or the same cause. In the following sections, I consider events in which the RAG complex causes the breaks on both chromosomes, referred to as RAG-type events at both chromosomal locations (that is, RAG-type-RAG-type translocation or deletion ; FIG. 2) . In other cases, AID can initiate damage, causing a DSB on one chromosome (an AID-type break) and the RAG complex would cause the break at the other chromosome (that is, RAG-type-AID-type translocation or deletion). Or both breaks can be AID-type. In yet other cases, a break may be of uncertain origin: not RAG-type or AID-type, but perhaps due to one of the general causes mentioned above such as oxidative damage or replication across a DNA nick. I refer to these as 'uncertain-type' breaks, and these are generally random in location. In the following section, I address how these combinations of causes of breakage lead to the most common chromosomal translocations in human lymphomas and lymphoid leukaemias.
Features of human B cell translocations
Major human pro-B and pre-B cell translocations. Many human B cell malignancies involve translocations between the IGH locus and non-Ig loci on other chromosomes 1, [17] [18] [19] [20] . The breaks at the IGH locus are usually directly adjacent to V, D or J segments if the breaks are due to the RAG complex. The non-Ig loci most often include human translocations involving BCL1, BCL2, E2A (also known as TCF3), mucosa-associated lymphoid tissue lymphoma translocation 1 (MALT1) and cytokine receptor-like factor 2 (CRLF2), and these translocations occur when the incipient neoplastic cell is a pro-B or pre-B cell 1, [17] [18] [19] [20] (FIG. 2) .
It is important to note that the neoplasms arising from pro-B or pre-B cells in which translocations have occurred often differentiate into mature B cells before they give rise to lymphoma 21 . This is the case for follicular lymphoma (FL), mantle cell lymphoma (MCL), mucosaassociated lymphoid tumour (MALT) lymphoma and diffuse large B cell lymphoma (DLBCL), which have the cell surface phenotype of a mature B cell rather than that of an early B cell. Thus, the initial characteristic translocation occurs at the early B cell stage (pro-B or pre-B cells), but the cells differentiate further along the B cell pathway before transforming into a mature B cell lymphoma 1 . RAG-type events at the IGH locus in these translocations are most often created by 'failed' D H to J H recombination events 15, 16 . Recombination events are considered 'failed' in the sense that normally the D H and J H regions join to one another but, in these pathological cases, the D H and J H regions join instead to the DNA ends at a DSB in a non-Ig locus. The DSB at the non-Ig locus is usually not at a recombination signal sequence (RSS) site 15, 16 , and hence, is not a RAG-initiated DSB. On the basis of inferences described below, these breaks are AID-type events. Thus, these major translocations in lymphomas or lymphoid leukaemias are RAG-type-AID-type events, and these are more common in terms of incidence and mortality among human B cell lymphomas. figure) . An RSS contains conserved heptamer and nonamer sequence elements, separated by either 12 or 23 non-conserved base pairs, hence the designation 12-RSS and 23-RSS. One recombination event requires one 12-RSS and one 23-RSS, and this is called the '12/23 rule'. Along with the constitutively expressed high mobility group box 1 (HMGB1) protein, the early lymphoid-specific recombination activating gene 1 (RAG1) and RAG2 proteins form the RAG complex, which nicks and then hairpins the DNA ends at the V and J segments (see the figure) . The Ku complex (comprising KU70-KU80) can bind to any of the four DNA ends. The Artemis-DNA-dependent kinase catalytic subunit (DNA-PKcs) complex then binds to the V and J hairpin ends and nicks the hairpins in a manner that usually results in a 3′ overhang. The Artemis-DNA-PKcs complex can then further endonucleolytically resect at any 3′ or 5′ overhang. DNA polymerase μ (Pol μ) and Pol λ can fill in the gap in a template-dependent manner. The ligase complex includes XRCC4-like factor (XLF; also known as Cernunnos), XRCC4 and DNA ligase IV. Some antigen receptor loci have not only V and J segments, but also D segments; hence, the name V(D)J recombination. Terminal deoxynucleotidyltransferase (TdT) is also expressed in early T and B cells, and it is responsible for most of the junctional addition of nucleotides, which is the major factor in what is called junctional diversity. NHEJ, non-homologous DNA end-joining.
Cμ Cγ3
Alternative DNA end-joining figure) ). Thus, the IGH locus DSBs in these events are usually created during IGH CSR.
Studies in mice have shown that MYC breakage is dependent on AID 26 . For human translocations, the MYC and BCL6 translocations occur at DNA sequence motifs for which the AID enzyme has a known predilection 20 , as discussed further below. Thus, the breaks at BCL6 and MYC are AID-type events, and the breaks at the IGH-S regions are also AID-type events (as part of the IGH CSR process). Thus, these human translocations between IGH-S regions and BCL6 and MYC are AID-type-AID-type events.
Although some inferences about translocation mechanisms can be discerned from the gene loci involved, precise sequence information is necessary for determination of the biochemical mechanism of the translocation, as discussed in the next section.
Sequence motifs at chromosomal breaks AID-type breaks at CpG and WGCW motifs. One important way to determine the cause of spontaneous chromosome breaks is to ascertain whether the breaks preferentially occur near any specific DNA sequence. For translocations that occur in various B cell malignancies in human patients, two DNA sequence motifs are located at or near breaks at an elevated frequency, which is highly statistically significant (P < 10 The palindromic Cs in WGCW are well known to be the optimal site of cytosine deamination activity by AID [27] [28] [29] . The Cs in CG sites are also distinctive for being potential sites of DNA methylation (mCpG). AID can deaminate cytosines at CG as well as at the methylated cytosine of CG 27, 30 , thereby creating a U:G or T:G mismatch, respectively. It is noteworthy that CG and GC (the core of WGCW) are the only two sequences that have C adjacent on opposite strands of the DNA duplex. The potential for two adjacent U:G or T:G mismatches probably favours the formation of DSBs during repair of each deaminated C because repair is occurring at two sites across from one another in the DNA helix.
The identification of CG and WGCW as sequence motifs is the strongest evidence to date implicating AID as the cause of DSBs in human lymphoid chromosomal translocations because, before this, only mouse data for Burkitt lymphoma were available, and the correspondence to other types of lymphoma in humans was not clear 1, [17] [18] [19] [20] A direct molecular test using replicating human minichromosomes documented the role of AID and the methylation of CG sites in the translocation break process 31 . There are three mechanisms by which a mismatch site created by AID could lead to a DSB: creation of an abasic site by DNA glycosylase, followed by apurinicapyrimidinic endonuclease 1 (APE1; also known as APEX1) activity; action by the Artemis-DNA-dependent kinase catalytic subunit (DNA-PKcs; also known as PRKDC) nuclease complex; or endonuclease action by the RAG complex (Supplementary information S6 (figure)). I have proposed that the Artemis-DNA-PKcs complex may be responsible for most of the DNAcutting events because this would account for how DSBs in two different locations in the genome (for example,
Box 2 | Mammalian immunoglobulin heavy locus class switch recombination
Mammalian immunoglobulin heavy (IGH) switch (IGH-S) regions form R-loops upon transcription, and these have now been demonstrated to be important for the efficiency of IGH class switch recombination (CSR) 47, 48 (see the figure, panel a).
Activation-induced deaminase (AID) requires single-stranded DNA (ssDNA) to recognize cytosine (C) as a substrate, and R-loops provide a fully single-stranded non-template strand. AID has a preference for C that is surrounded by the sequence WGCW, where W = A or T (see the figure, panel b) . But AID can deaminate any C to a U (and any methyl-C to a T, although at somewhat lower efficiency) 30 . Once AID has converted some of the C residues in the switch region to U, then uracil-DNA glycosylase (UDG; also known as UNG) can remove the U to create an abasic site. Next, apurinic-apyrimidinic endonuclease 1 (APE1) can create a nick at the abasic site (dashed line in the figure, panel c). This explains nicks on the non-template strand 92 . RNase H can remove portions of the RNA (RNA is shown as a red line in the figure) that are annealed to the template DNA strand, thereby exposing ssDNA regions -thus enabling AID-UDG-APE1 action there as well (depicted as a gap in the bottom image of the figure, panel d) . AID 
Fragile sites
Some regions of DNA in the human genome are 10-to 1,000-fold more likely to be a site of breakage or translocation. The fragile sites or zones in this Review occur in otherwise normal patients and these fragile sites or zones are 20-2,000 bp in length. These naturally occurring sites are to be distinguished from the fragile sites or FRA sites that can be induced by DNA polymerase chain terminators or poisons such as hydroxyurea, because these are 300,000 to 10,000,000 bp in length.
Immunoglobulin heavy (IGH) locus class switch recombination
The DNA recombination process by which the heavy chain isotype is changed from making IgM to making IgG, IgA or IgE.
one DSB initiated by AID and one DSB initiated by the RAG complex) could occur within a constrained time interval 31 (Supplementary information S6 (figure)). If the DSBs occur at widely separate times, then one would expect more nucleotide resection than is actually observed. Further work will be required to provide clarity on how close in time the two DSBs occur and what factors account for them physically coming together. It is possible that high-resolution microscopy or singlemolecule fluorescence methods may provide future insight on this 32, 33 . Direct evidence in mice and humans for the activity of AID in these translocations showed that cytosine deamination at CGs is enriched throughout the genome in samples from patients with acute lymphoblastic leukaemia (ALL) 34 ; human fetal liver and bone marrow B cell precursors have both active AID and active RAG1-RAG2 proteins; concurrent enzyme expression of RAG1-RAG2 and AID occurs in single mouse pre-B cell clones and in human pre-B ALL clones; inflammatory cytokine stimuli increase the chromosomal damage caused by simultaneous expression of AID and RAG1-RAG2 (the damage includes chromosomal deletions, insertions and inversions, in addition to chromosomal translocations 34 ). The molecular and cellular data provide compelling support for the concept that AID-initiated mismatches explain a large number of human B cell lymphoma chromosomal breaks. Future work in this area could focus on the balance of the various causes: AID-type to RAG-type translocations versus RAG-type to RAG-type or AIDtype to AID-type translocations. Additionally, greater insight into the types of viral or bacterial infection that increase AID expression or activity levels in human pre-B cells would be valuable for understanding how these contribute to increases in lymphoid malignancies in children 34 . RAG-type breaks at CAC motifs. RAG-type breaks almost always occur at CAC sequences, because this is the essential portion of the heptamer of all RSSs. In human T cell malignancies, the RAG complex can cause interstitial deletions quite commonly. Most notably, in pre-T cell acute lymphoblastic leukaemia (T-ALL), the RAG complex often causes breaks at both SCL (also called TAL1) and SCL-interrupting locus (SIL; also known as STIL) 35, 36 . Deletions due to RAG complex activity also occur at cyclin-dependent kinase inhibitor 2A (CDKN2A; which encodes p16
INK4A and p14 ARF ) in human T-ALL 37 . In the designation system used here, these are all RAG-type-RAG-type deletions. This propensity for interstitial deletions may simply reflect that the RAG complex can bind to the RSS more readily when they are tethered together on the same DNA molecule 38 . This is because the synaptic assembly of the RAG complex with two RSS or pseudo-RSS sites will be faster for RSSs that are nearby on the same chromosome 39 . In mouse models that involve aberrant expression or mutant forms of the RAG complex, RAG activity at CAC motifs is unusually common compared with wild-type mice [40] [41] [42] . Less common than the interstitial (intrachromosomal) deletions are RAG-type-RAG-type translocations in human T-ALL 43 . Examples include T cell receptor (TCR) locus translocations with the SCL, LIM domain only 2 (LMO2), homeobox 11 (HOX11; also known as TLX1) and TTG1 (also known as LMO1) loci in T-ALL 43, 21 (FIG. 2) .
A small percentage of human B cell malignancies also seem to involve interstitial deletions caused by the RAG complex acting at both DSBs (RAG-type-RAG-type events), such as the CRLF2-purinergic receptor P2Y8 (P2RY8) deletion on the X-chromosome in some human pre-B ALLs 44 .
Box 3 | Mechanistic aspects of immunoglobulin somatic hypermutation
Although it is not fully understood, some of the known elements of the somatic hypermutation (SHM) process are shown in the figure. Activation-induced deaminase (AID) requires single-stranded DNA (ssDNA) 27, 30 . In contrast to immunoglobulin heavy (IGH) class switch recombination (CSR), in which stable kilobase-length R-loops provide ssDNA, for SHM at physiological loci (primarily IGH and immunoglobulin variable (IGL V) segments), the ssDNA may arise simply from transcription, which is accompanied by transient underwinding of the double-stranded DNA as the RNA polymerase passes through a region. After AID-mediated deamination of C to U (or methyl-C to T) on either strand of the DNA, then either of two error-free mechanisms may repair the site, without mutation. These two error-free mechanisms are base excision repair (BER) and mismatch repair (MMR). But in SHM, any of three error-prone pathways may operate. First, an error-free DNA polymerase may simply copy the U, which is read as a T, resulting in a C:G to T:A transition. Second, uracil-DNA glycosylase (UDG) will remove the U, and apurinic-apyrimidinic endonuclease 1 (APE1) will nick 5′ to the abasic site. This will then enable an RNA-directed polymerase (REV1)-dependent transversion to result. Third, after UDG and APE1 action, exonuclease 1 (EXO1) can resect downstream of the nick site, providing a long gap that is filled in by the error-prone DNA polymerase η (Pol η). Pre-B ALL cells that already have an ETS variant 6 (ETV6)-runt related transcription factor 1 (RUNX1; also known as TEL-AML1) translocation (by an undefined mechanism) subsequently acquire secondary deletions, inversions, insertions and translocations at off-target CAC motifs owing to continuous production of the RAG complex in the pre-B cells 45 . A common inversion on human chromosome 7 occurs between the physiological RSS sites located at the ΤCRΒ (also known as TRB) locus (at 7q35) and the TCRG (also known as TRG) locus (at 7p14) 43 . Both DSBs are RAG-type events at RSS sites in antigen receptor loci. This inversion can be seen in the peripheral blood of normal individuals and is of no known clinical importance 21 . In summary, RAG-type-RAG-type translocations account for translocation in T-ALL in T cells, which do not express AID. But in B cells, the co-expression of the RAG complex and AID is responsible for the most common translocations. Given the involvement of AID, it is important to consider next the DNA structural requirements of AID.
AID DNA substrate requirements AID acts only at cytosines that are in regions of singlestranded DNA (ssDNA) 27, 30 . Large zones of ssDNA can be created when an R-loop is formed [46] [47] [48] . It has been shown that R-loops form at IGH-S regions and that this is physiologically important for IGH CSR to occur [47] [48] [49] . The stability and kilobase-length of R-loops provides ample ssDNA for efficient AID action during IGH CSR [47] [48] [49] . In contrast, Ig SHM (which is also called affinity maturation) is a slower process, perhaps in part because the generation of ssDNA during transcription is transient, short in length and does not involve stable R-loop formation
.
Like the physiological sites for AID action, pathological or off-target sites of AID action must also have at least transient ssDNA character. The most common oncogene targeted by AID is MYC, which accounts for >90% of translocations in lymphomas in most B-cell lymphoma mouse models 4, 50 (whereas MYC translocations account for ~3% in human lymphomas, discussed further below). One study using a monoclonal antibody (called S9.6) against RNA:DNA duplexes, has raised the possibility of a genomic R-loop at the exon1-intron1 junction of MYC, where most translocations occur 51 . However, the S9.6 antibody is crossreactive with RNA:RNA duplexes, and this currently precludes a conclusive statement about R-loops at this location in the genome 52, 53 . If more rigorous studies demonstrate an R-loop at the exon1-intron1 boundary of MYC, it would explain the action of AID at this location.
Divergently directed transcription is known to generate transient ssDNA between the diverging RNA polymerases 54, 55 . The vulnerability of transcriptionally active regions to AID activity has been demonstrated in mouse models 56, 57 . This is highly relevant to the human BCL6 gene 56 , which undergoes translocations to the IGH-S region by an AID-type-AID-type mechanism 20 (Supplementary information S7 (figure)). The 2 kb BCL6 fragile zone is delimited by the BCL6 promoter and a non-coding RNA (ncRNA) region so precisely that it suggests a causal role that limits the trans locations to this 2 kb zone rather than anywhere else within the remaining 9 kb of intron 1 of the BCL6 gene 58 . These two promoters are oriented in a convergent or opposing manner. However, once the two RNA polymerases have passed one another, the physical impact on DNA topology is the same as for divergent promoters, which After exchange of the chromosomal arms, the DNA ends are joined by non-homologous DNA end-joining (NHEJ) to generate the two derivative chromosomes. Such events are the predominant mechanism found in most human B cell lymphomas. c | Mature B cell translocations. An AID-type event on one chromosome can give rise to a translocation involving a failed IGH class switch recombination (CSR) event, which is a physiological AID-type event. CRLF2, cytokine receptor-like factor 2; MALT1, mucosa-associated lymphoid tissue lymphoma translocation 1; PBX1, pre-B-cell leukaemia homeobox 1. creates a region of underwound DNA that favours single-strandedness, making this region vulnerable to several nucleases 58 . Divergent versus convergent transcriptional effects on chromosome breakage have now been formally tested in Saccharomyces cerevisiae, and the results support the importance of both divergent transcription and topological tension due to convergent transcription 59 . Thus, relatively large zones with a high frequency of translocation, such as at BCL6, may be caused by divergent or closely positioned convergent transcription promoters.
Although fragile zones of a few kilobases may be explained by transient ssDNA generated at R-loops or by zones of divergent transcription, the reason for AID action at smaller zones of 20-150 bp is much less clear 1, [17] [18] [19] [20] . The BCL1 major translocation cluster (MTC) region is only 100-150 bp and lies within a transcriptionally inactive region. The BCL2 major breakpoint region (MBR) is not a site at which R-loops occur or a site of divergent transcription. The same applies to the BCL2 intermediate cluster region (ICR) and minor cluster region (MCR) and to the MALT1, CRLF2 and E2A fragile zones (FIG. 3) . We currently do not understand how these zones acquire a ssDNA state, but they must acquire some degree of single-strandedness in order for AID to act at cytosines in these zones. Direct repeats at some of these sites, which could give rise to strand slippage, have been identified 1 . Further studies are needed to elucidate the underlying cause(s) of the elevated frequency of DSBs at AID targets in these regions.
Timing of B cell translocations
The patient translocation sequence motifs, the junctions and the Ig partners provide information on several facets of the translocation process. First, for any trans location in which one of the partners is directly adjacent to a V, D or J segment of an Ig locus, the translocation probably occurred during pro-B or pre-B cell development because this is the phase when V(D)J recombination occurs (Supplementary information S3 (figure)). As mentioned above, analysis of the junctions of these translocations, regardless of the partner with which the Ig locus was translocated, showed that they frequently included evidence of TdT polymerase activity 1, [17] [18] [19] [20] . Because TdT expression is specific to pro-B and pre-B cells (and pro-T and pre-T cells), this confirms that these B cell translocation events occurred during early stages of B cell development. Although the translocations occur at the pre-B cell stage, most of the lymphomas, such as follicular lymphoma, DLBCL and MALT, have a cell surface phenotype of mature B cells (FIG. 4; TABLE 1 ). This indicates that after the translocation, the cells carrying the translocation differentiate into mature B cells. This suggests that a second hit is needed to convert these cells into neoplasms. This may involve point mutations to further upregulate the expression of the trans located gene or second translocations involving other oncogenes 25 . Second, the CG and WGCW motifs at the non-Ig partner loci indicate that AID is being expressed at the same time as RAG-mediated Ig gene rearrangement Figure 3 | A high proportion of breakpoints on BCL2, BCL1 and E2A fall into fragile regions that are smaller than 600 bp. Schematics of the BCL1 locus (which is near the cyclin D1 (CCND1) gene), E2A (also known as TCF3) and BCL2 regions illustrate clustering of breakpoints in the various identified cluster regions (orange starbursts). The breakpoints that do not fall into cluster regions are plotted randomly for illustrative purposes (blue vertical lines). In the BCL1 cluster (top), the major translocation cluster (MTC) is located ~110 kb from the CCND1 gene. The 150 bp MTC contains ~30% of breakpoints, whereas the remaining 70% of events are distributed widely over the surrounding 340 kb, as recently mapped and sequenced 19 . In the E2A cluster, which occurs in intron 13 of the E2A gene 84 , 75% of breakpoints occur in the 23 bp E2A cluster, whereas the surrounding 3 kb account for only 25%. In the BCL2 cluster, relative proportions of breakpoints at the BCL2 major breakpoint region (MBR), intermediate cluster region (ICR) and minor cluster region (MCR) are shown. In the third exon of the BCL2 gene is the MBR in the 3′ untranslated region (UTR), whereas the centromeric 29 kb contains the ICR and MCR. The 175 bp MBR, 105 bp ICR and 561 bp MCR account for ~50%, ~13% and ~5%, respectively, of the BCL2 translocation breakpoints. Every CG sequence motif in each of these three 'fragile zones' is a hot spot for human translocation. Fragile regions or zones for one of the oncogenes in this Review, BCL2, are shown, but the principles apply to the other fragile zones as well. Within each fragile zone, the actual translocations occur at DNA sequence motifs consisting of one of the sequences CG (CpG), mCG (when methylated) or WGCW, where W = A or T. Human lymphomas are clinically indistinguishable regardless of the position of the breakpoint within the 29 kb. We are trying to determine why these BCL2 and related zones at other loci (such as BCL1 MTC, E2A, mucosa-associated lymphoid tissue lymphoma translocation 1 (MALT1) and CRLF2) are highly preferred for DNA breakage and translocation. In the expanded MBR DNA sequence diagram (bottom line of figure) , the three bell curves illustrate the location of most BCL2 MBR breaks. The breakage frequency within this 175 bp region is 300-fold higher than what one would expect to occur at random. Patient-associated breaks within the MBR are not uniformly distributed across the entire 175 bp, but instead are focused in three peaks (bell-shaped areas), and there are CG sequence motifs located near the centre of each peak 1 . The P values for the proximity of the MBR breaks to CG sites are between 10 −42 and 10 −96 (highly significant). The importance of CG and WGCW as translocation sequence motifs applies not only to the BCL2 gene, but also to most other human B cell neoplastic chromosome translocations. For example, breaks at the MTC of the BCL1 gene are also located near CG sites (P values of 10 −9 to 10 −13 ), and breaks on the telomeric side of the MTC are significantly close to WGCW sites. In the MALT1 gene translocations to IGH in human mucosa-associated lymphoid tissue (MALT) lymphomas (FIG. 2) , the breaks are also located at CG sites (P = 0.002). The proximity of CG to breaks applies also to the E2A gene translocations (P = 10 −4 ) and the CRLF2 gene translocations to IGH (P = 0.0004) in human pre-B acute lymphoblastic leukaemia (ALL). Chr, chromosome; Ex, exon. 
Portions of a complete variable domain exon. I call these subexons. The V, D and J segments have recombination signal sequences (RSSs) located next to them to enable the recombination activating gene (RAG) complex to bind and cut to initiate the V(D)J recombination process.
in the pro-B and pre-B cells. There have been many reports demonstrating AID expression in both mouse and human pre-B cells 34, [60] [61] [62] [63] [64] [65] [66] [67] [68] . The level of expression is low compared with that in germinal centre B cells, but it seems to be sufficient to catalyse the low but important incidence of human lymphoid neoplasmassociated translocations 1, 8, [17] [18] [19] [20] 34 . Translocations involving at least one chromosome with an AID-type break account for nearly half of all human haematopoietic malignances 1, [17] [18] [19] [20] (FIG. 5) .
Translocations in patients and mice Several important studies in mouse and cellular model systems have provided interesting information about the translocation process 3, 4, 56, 57, [69] [70] [71] . In mice that spontaneously develop B cell lymphoma or develop lymphoma after being injected intraperitoneally with the immunological adjuvant oil pristane, translocations of MYC account for nearly all of the tumours (>90%) 72 . This is in contrast to humans, in which MYC is translocated in only 3% of human B cell malignancies (and almost never in other neoplasms) 21 . Studies have shown that Myc translocations in mice require AID 26 . In contrast to translocations that occur in patients with B cell neoplasms, no AID-preferred DNA sequence motifs were initially identified at the break sites in Myc in the mouse studies. Re-analysis of Myc breakpoints in spontaneous and pristaneinduced mouse lymphomas identified AID motifs, specifically WGCW 20 . But this was possible only after the WGCW motif was first identified in human patient MYC translocations 20 . Many mouse lymphoid neoplasm translocation models use the I-SceI endonuclease (which cleaves double-stranded DNA (dsDNA) at long recognition sequences) to create a defined DSB at a specific location (for example, in Myc), and then this DSB is used to do a genome-wide search to determine the location of preferred spontaneously breaking partners 73 . From these studies, it was determined that gene promoters are preferred sites of breakage, perhaps because these regions may have open chromatin and some degree of ssDNA character owing to the melting of the promoter(s) by RNA polymerase II. Further studies have shown that mouse promoters are often sites of non-coding RNA transcription that might cause changes in local DNA topology, further accounting for the observations in mice 56, 57 . Of note, the most common translocation fragile zones in humans (BCL2, BCL1, E2A, MALT1 and CRLF2) are not at promoters (or enhancers), illustrating a key difference between translocations observed in mouse models and those observed in human lymphoid neoplasm translocations.
Replication stress has been raised as another factor that drives translocations in mouse models, involving the use of replication poisons or inhibitors of DNA repair enzymes 74 .
Breakage zones in such models cover megabasesized regions, just as they do for the common fragile sites in humans, when replication poisons are used to treat cultured human cells 74, 75 . The breakage zone around the mouse Bcl2 gene covers 100,000-1,000,000 bp in one mouse model 74 . This is quite distinct from the naturally arising human translocation breakage zones at the BCL2 gene, which are a few hundred base pairs in size 1 . This illustrates that mouse models of lymphoid translocations fail to recapitulate many key aspects that are relevant to lymphomagenesis in humans. The Bcl2 breakage zone in mice is so broad that it certainly has nothing to do with the 100-600 bp fragile zones downstream of the human BCL2 gene 1 . This is not surprising given that these fragile zones in human are not conserved in sequence between mice and humans. 
Peyer's patches
Gut-associated lymphoid tissue (GALT) within the ileum of the small intestine, which can form germinal centres.
Minichromosomes
In experimental systems, stable replicating plasmids are called minichromosomes. In human cells, Epstein-Barr virus (EBV) or simian virus 40 (SV40) origins of replication can drive replication of these minichromosomes with the help of the EBNA1 protein or SV40 large T antigen helicase, respectively. In mouse or rat cells, the polyoma virus origin of replication can serve this purpose, with the support of the polyoma large T antigen helicase.
Pseudo-RSS
A sequence that is similar to a recombination signal sequence (RSS), in having sequences that bear some similarity to the RSS heptamer and nonamer. A pseudo-RSS is not adjacent to a V, D or J segment, and thus has no function. But the RAG complex can cut at a pseudo-RSS to cause a deletion or translocation.
Factors relevant to translocations Some translocations create a neoplastic cellular proliferation advantage 76, 77 . In this Review, the focus has been on the factors that make some very localized (20-600 bp) DNA sequences particularly prone to translocation events in many patients (for example, BCL2, BCL1, E2A, MALT1 and CRLF2). These very small or localized zones can be 10-to 1,000-fold more likely to be the site of translocation (breakage) than DNA immediately adjacent to or within larger zones (for example, 29-31 kb, as in the case of the BCL2 gene, or 340 kb, as in the BCL1 translocation) 1, 19 . Malignancies that arise from DSBs and translocations outside the fragile zones do not seem to be clinically distinguishable from those that arise from DSBs and translocations inside the fragile zones 1, 19 . Some rearrangements result in the formation of chimeric fusion transcripts from two genes, such as the t(1;19) translocation involving E2A and pre-B-cell leukaemia homeobox 1 (PBX1) [78] [79] [80] [81] [82] [83] . In this case, the DSB could occur at any point across much of the length of a given intron in each gene so as to create the neoplastic fusion transcript. This is the case for the PBX1 gene, in which breaks occur at any location in a single intron 84 . These DSBs are likely to be random and due to mechanisms such as ROS activity, exposure to ionizing radiation or aborted topoisomerase II reactions. But, at the E2A locus, AIDtype breaks are localized to a 23 bp zone that is <1% of the size of the 3.2 kb intron in which it occurs.
Similar principles apply to the t(9;22) translocation that occurs in chronic myeloid leukaemia (CML) and the t(9;22) translocation in a subset of ALLs in which the BCR and ABL1 genes fuse, producing a fused transcript encoding the oncogenic p210 (REF. 85 ). DSB formation at both the BCR and ABL1 loci occurs over broad translocation zones (5.8 kb in the BCR gene and ~200 kb in the ABL1 gene) [86] [87] [88] [89] . Among the various BCR-ABL1 translocations that give rise to malignancies, this fusion gene contains at least the first exon of BCR, which encodes an oligomerization domain, and frequently contains exons 2-11 of ABL1, which encode the tyrosine kinase [86] [87] [88] [89] . The 200 kb breakage zone in ABL1 contains translocation break sites distributed randomly within alternative exons 1a and 1b. The 5.8 kb breakage zone in BCR is the major breakpoint cluster region (M-BCR), encompassing exons 13 and 14. A minor BCR, which is ~130 kb in length in intron 1, can give rise to a shorter fusion gene encoding p190 (REFS 85, (86) (87) (88) (89) . Leukaemia arises from this event only when the resulting mRNA encodes a functional protein [86] [87] [88] [89] . Thus, only some splice combinations produce a functional BCR-ABL1 fusion protein. Therefore, it is not the higher breakage frequency in BCR that makes it a translocation zone; instead, it is the growth advantage provided by the resulting functional BCR-ABL1 fusion protein that determines the boundaries of this translocation zone.
Again, the DSBs in both BCR and ABL1 are likely to be due to random causes (for example, ROS activity, ionizing radiation exposure or topoisomerase reaction failures). Therefore, it is useful to distinguish between localized hot spots (that is, high concentrations of breaks in small zones within the total breakage zone, usually <600 bp), as in the BCL2, BCL1 and E2A examples, and broad translocation zones that often span the length of an entire intron (usually a few kilobases or even 10-100 kb in length), as in BCR-ABL1.
For translocations involving small, localized hot spots (20-600 bp), there are two major factors that make the translocation biologically apparent -the increased propensity for DSBs at the fragile zone and the resulting cellular growth advantage provided by the gene fusion product (TABLE 1) . By contrast, translocations that are not the result of hot-spot propensity give rise to a malignancy when the growth advantage alone brings the translocation to the level of clinical attention 1 .
Future questions
Molecular basis for the fragile zones in human B cell lymphoma. The breaks at the BCL2 and BCL1 fragile zones occur near CG motifs located in 20-600 bp zones, but not at CG sites immediately outside these zones 1, 19 . We do not know why the CGs inside the fragile zone are the only ones that are vulnerable. There are many possible explanations, such as strand slippage between repeats or unusual interactions between certain DNA sequences and the histone octamer. Further studies are needed to experimentally examine these possibilities.
WGCW versus CG motifs in human B cell lymphoma.
We cannot yet explain why some human B cell translocations (BCL2 or BCL1 MTC, CRLF2, MALT1 and E2A) occur at CG motifs but not at WGCW motifs, whereas the BCL1-associated breaks that occur outside the MTC are located at either CG or WGCW motifs.
Similarly, we do not know why the MYC and BCL6 translocations occur at the 4 bp WGCW motifs, but not at the 2 bp CG motifs. Of special note, the MYC and BCL6 translocations usually also have point mutations 
The focus of this Review is on translocations in the first two columns, which represent hot spots of breakage. Some translocations arise because they generate a fusion protein, and the break can be anywhere in (or in large portions of) specific introns (as shown in the Larger zones column). CRLF2, cytokine receptor-like factor 2; ETV6, ETS variant 6; ICR, intermediate cluster region; MALT1, mucosa-associated lymphoid tissue lymphoma translocation 1; MBR, major breakpoint region; MCR, minor cluster region; MLL, mixed lineage leukaemia; MTC, major translocation cluster; RUNX1, runt related transcription factor 1. *The BCL6 translocation is included in this column because it occurs in a region demarcated by two convergent promoters (the BCL6 promoter and the promoter for a non-coding RNA (ncRNA)) 58 . The MYC translocations occur in a region that preliminary data suggest forms an R-loop 51 .
Chronic lymphocytic leukaemia (12%)
Chronic myeloid leukaemia (4%) BCR-ABL1 t(9;22)(q34;q11) >90-95% 
Divergently directed transcription
Two promoters can be close to one another and directing transcription away from one another. Approximately 10-20% of the human genome has divergently directed promoters, depending on non-coding RNAs.
near the translocation junction, but the CG motifs at the BCL2, BCL1, CRLF2, MALT1 and E2A translocations only rarely have such mutations. The WGCW motifs are within transcribed zones and are much larger regions (~2 kb), whereas the CG motifs are not in transcribed zones and are found in smaller clusters of 20-600 bp.
Other neoplasms and other facets of translocations.
Some studies have suggested that the proximity of the two chromosomes to each other may be important for the translocation event 32, 70, 90, 91 . Clearly, after the DSBs have occurred, the DNA ends must come into proximity to be joined. But does chromosomal proximity predispose to translocation? There is no evidence in human lymphoid neoplasms that proximity is an important factor in translocations. Instead, the DNA breakage process seems to be the rate-limiting step, and studies in mouse systems support this interpretation 50 .
It is interesting that epithelial tumours usually have non-reciprocal translocations in contrast to haematopoietic malignancies, which more often have reciprocal translocations 5 . We do not know the mechanistic basis for this difference.
Concluding comments
I have reviewed the biochemical mechanism of translocations for a major fraction of human lymphomas. For T cell lymphomas, RAG-type-RAG-type combinations are common in translocations. For most B cell lymphomas, RAG-type-AID-type combinations are most frequent, such as at the BCL2 gene, the BCL1 MTC, CRLF2 and MALT1. For AID-type breaks that use the CG motif, although we now understand most aspects of the biochemical mechanism of breakage, we do not yet know why they occur in precise 20-600 bp zones. 94 . The translocations and their percentage in each malignancy are estimated from Swerdlow et al. 21 The portion of translocations that involve at least one activation-induced deaminase (AID)-type event, often at the oncogene, are shown with orange dashed outlines. Some are AID-type-AID-type events, such as translocations between BCL6 or MYC and the immunoglobulin heavy (IGH) switch regions. But most are AID-type-recombination activating gene (RAG)-type events, such as BCL1, BCL2, mucosa-associated lymphoid tissue lymphoma translocation 1 (MALT1) or cytokine receptor-like factor 2 (CRLF2), to the IGH locus during failed D H to J H joining. The small fraction outlined with blue dashed lines are RAG-type-RAG-type events. Note that many other translocations are not included (for example, BCR-ABL1 translocations also occur in some B cell lineage acute lymphoblastic leukaemia (ALL); and mixed lineage leukaemia (MLL)-AF9 occurs in some cases of acute myeloid leukaemia (AML)) as this figure is not intended to be comprehensive; readers are referred to the current American Cancer Society website and Swerdlow et al. 21 for further details. ALK, anaplastic lymphoma kinase; CCND1, cyclin D1; CDKN1A, cyclin-dependent kinase inhibitor 1A; ETO, eight twenty one protein; HOX11, homeobox; NPM1, nucleophosmin; PBX, pre B cell leukaemia homeobox 1; PML, promyelocytic leukaemia; RARA, retinoic acid receptor-α; SIL, SCL interrupting locus; TAF8, TATA-box binding protein associated factor 8; TCR, T cell receptor; WHSC1, Wolf-Hirschhorn syndrome candidate 1; WWOX, WW domain containing oxidoreductase.
